News for Inogen, Inc. (INGN)

On March 3, 2025, Smith Kevin Raymond Merrill, CEO and President of Inogen Inc, purchased 11,709 shares of Inogen Inc (INGN). Following this transaction, the in

On March 3, 2025, Michael Bourque, Executive Vice President, Chief Financial Officer & Treasurer of Inogen Inc, purchased 3,000 shares of the company. Following

Inogen shows solid B2B growth, but guidance and margin issues hurt sentiment. Learn why INGN stock is a speculative play with long-term growth potential.

Total Revenue (Q4 2024): $80.1 million, a 5.5% increase year-over-year.Domestic B2B Revenue (Q4 2024): $22.4 million, a 24.1% increase year-over-year.Internati

Feb 25, 2025 / 10:00PM GMTOperator Welcome to Inogen's fourth-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is b

Inogen, Inc. (NASDAQ:INGN) Q4 2024 Earnings Conference Call February 25, 2025 5:00 PM ETCompany ParticipantsRyan Peterson – Investor RelationsKevin Smith –...

The following slide deck was published by Inogen, Inc.

Inogen (INGN) delivered earnings and revenue surprises of 28.07% and 0.73%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Quarterly Revenue: $80.1 million, surpassing the estimated $73.91 million, reflecting a 5.5% increase year-over-year.Quarterly EPS: Reported at -$0.41, outperf

[url="]Inogen, Inc.[/url] (Nasdaq: [url="]INGN[/url]), a medical technology company offering innovative respiratory products for use in the homecare setting, t

Fresenius Medical, Masimo, Merit Medical Systems and Inogen are included in this Analyst Blog.

Inogen Inc (INGN) is set to release its Q4 2024 earnings on Feb 25, 2025. The consensus estimate for Q4 2024 revenue is $73.91 million, and the earnings are exp

INGN and Yuwell collaborate to expand and enhance Inogen's innovation pipeline through R&D collaboration and accelerate the entry of Inogen's brand into the Chinese market.

Arab Health 2025｜Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health

Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell

Shares of Inogen Inc (INGN) surged 4.31% in mid-day trading on Jan 24. The stock reached an intraday high of $11.97, before settling at $11.56, up from its

Inogen (INGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

INGN's revenue growth in the fourth quarter is likely to have been boosted by continued robust adoption of its products.

Shares of Inogen Inc (INGN) surged 3.59% in mid-day trading on Jan 14. The stock reached an intraday high of $11.62, before settling at $10.70, up from its